This study examines the feasibility of using Quality-Adjusted Life Years (QALYs) to assess patient outcome and the economic justification of treatment in an Intensive Care Unit (fCU).
Treatment of patients in Intensive Care Units (ICU) is expensive, and the justification for ICU treatment has been questioned on clinical, ethical and economic grounds i,2. The economic justification of any treatment requires comparison of patient outcomes and cost of treatment with other medical interventions that also require financial support. Cost-utility analysis is a type of economic evaluation which may facilitate such comparison.
Outcome after an acute illness has traditionally been assessed by survival. To incorporate differences in both quality and duration of survival, a unitary measure of outcome, the "Quality-Adjusted Life Year" (QALY) has been suggested]". For example, a patient who gains ten years of life, with a quality of 60070 of normal, has gained six QALYs. Thus, a disease causing only morbidity can be compared with diseases causing mortality. Hence, QALYs have been suggested as an economic justification of ICV treatment. The outcome of a group of patients treated in our ICV was quantified using QALYs, the total and marginal costeffectiveness (cost per QALY) of treatment of these patients estimated, and these results compared with published cost-per-QALY estimations for other medical interventions.
METHODS

Patients
At the time of the study, Liverpool Hospital was a 420-bed general hospital with a six-bed Intensive Care Vnit (lCV), but without cardiothoracic surgery, acute neurosurgery, or a burns service. Three hundred consecutive admissions to the ICV, from February to August 1986, were studied. Readmissions to the ICV during one hospital stay were treated as a single admIssion. Patients transferred from this ICV to other units remained in the study. Initial admission data included the severity of illness, recorded using the APACHE 11 score l6
•
Study Method
The study was approved by the Hospital Ethical Review committee. Patients were followed up in July 1989. Patients admitted after self-poisoning were not included. Patients were traced by a variety of methods, including direct and indirect contact, tracing medical records, and checking death records kept by the Registrar of Births, Deaths, and Marriages. Survivors were interviewed by telephone by one of the authors. The interview, including explanation and questionnaire, took approximately ten minutes. Subjects were then sent the identical questionnaire to be self-completed. In some cases the questionnaire was completed by telephone or mail alone. Where patients could not supply adequate information, assistance was obtained from relatives, or medical and nursing staff.
The questionnaire was in three parts: 1. General questions about the patient's health since discharge from hospital, as well as their current activities of daily life. Answers were unstructured. Subjects were also asked to describe their current health, and quality of life, on a six word scale: (excellent! good/ satisfactory / fair/ poor/terri b le questionnaire was analysed to produce a quality of life value (Rosser Index value) for each patient contacted (Appendix 1).
Calculation of Outcome in QALYs
The quality of life of survivors was measured using the Rosser Index, as described. Survivors at follow-up were assumed to have a life expectancy of 90070 of agespecific life expectancy, and a stable future quality of life, as has been suggested in previous studies 19·28 . The estimated survival was discounted at a rate of 5% annually to reflect the greater value of immediate versus longterm survival. Patients who had not survived to follow-up, or who were not contacted, were assumed to have had a quality of life equal to the mean quality of life of survivors in the same diagnostic group. Vsing these assumed values for quality of life in nonsurvivors, and future life-expectancy of survivors, QALYs were calculated for each patient.
The general formula for the calculation of patient outcome in discounted QALY is thus: For each patient:
where: Q= Quality of life value (Rosser Index) R = Discount rate (5% per annum) s = Duration of survival in years:
If dead at follow-up, s=time from ICV admission until death. If alive at follow-up, s=0.9 (age-specific life expectancy at admission)
Marginal effect of fCU treatment
The marginal effect of ICV treatment on acute survival was estimated using a modified two-round Delphi technique 29 . Senior intensivists in six major ICVs in Sydney were asked to estimate the relative survival of hypothetical patients with different severity of illness (APACHE 11 score), if they were treated in an ICV or in a normal ward. The average of the survival estimates was used as the relative survival rate for different severity of illness. A relative survival rate of 0.65 implies that 65% of patients who did survive following ICV treatment would have survived following normal ward care.
Patient outcome that would have followed normal ward care was estimated by reducing the estimated outcome (QALYs) for each patient by the relative survival rate for that patient's severity of illness (APACHE 11 score). The difference between these values represents the "marginal QALY gain" due to ICV treatment.
Estimation of Cost of Treatment and Cost-Effectiveness
Public hospital care in Australia is free, and accurate information about the cost of treating an individual patient is impossible to obtain. At the time of the study, the ICU was not economically independent. The hospital had a global budget that included costs for all staff payments, pharmaceuticals, diagnostic services, ancillary services, patient "hotel" services, and disposables. Capital and building costs were not included. Staffing levels for wards and specialist units were fixed independently of day-to-day variations in clinical load and patient dependencies. The limited information available necessitated estimation of the cost of treatment of an individual patient based on the average daily bed cost per patient for the hospital. Based on previous studies lol2 , it was estimated that treatment in ICU was three times more expensive than treatment in a normal ward.
In order to estimate the total and marginal costeffectiveness of ICU treatment, it was necessary to estimate for each patient: 1. the cost of treatment following ICU admission; and 2. the costs that would have been incurred if all patients had been treated on a normal ward.
Cost of treatment following ICU admission was calculated from the duration of treatment in hospital using the formula:
Cost=[(days in ICU)+(days in normal ward)] x RSR + 4.8 [1-RSR]) x average daily bed cost.
As described above, it was assumed that treatment in a normal ward would reduce patient survival, leading to a reduced average length of stay per patient treated. The estimated cost of treatment for the hospital survivors in our series if they had been given standard ward care only, was thus calculated based on estimated relative survival rates (RSR) using the formula:
This includes 4.8 days treatment before death for additional non-survivors which was the average for non-survivors in our series. The relative survival rate (RSR) for each patient was determined by the APACHE 11 score for that patient.
Cost of normal ward treatment of hospital nonsurvivors from the original series was estimated on the assumption of an unchanged length of stay, as follows: Cost = [(days in lCU) + (days in normal ward)] x average daily bed cost.
The above calculations produced an estimate of the cost of treatment that was given, and the costs that would have arisen if only normal ward care had been given. Comparison of the different costs and outcomes achieved by lCU or normal ward treatment gives an estimate of 1. the total "cost per QALY" or cost-utility, of the treatment given, and 2. the marginal cost per QALY, or marginal cost-effectiveness, of ICU treatment.
There are many "QALY League Tables", giving comparative estimates of the cost per QALY of a variety of medical interventions, in the published literature. One such table based on the Australian Health System at the time of the study was used as an example for comparison with the results of this study33.
RESULTS
Patient Data and Survival
The characteristics of the patients studied are shown in Tables 1 and 2. The patient group studied was broadly similar to those reported in other general hospital Intensive Care Units in Australia and New Zealand, but may be different from the typical patient mix in the U.S.A.l4. There were no cardiothoracic surgery, neurosurgery, or burns patients, reflecting hospital services at the time. Excluding readmissions during the same hospital stay, two patients were admitted to the lCU twice. In these cases, only the first admission was included in the study. The 50 patients admitted 51 times after selfpoisoning were all discharged alive and not included in the study. Of the other 248 patients (249 admissions), Anaeslhesia and Inlensive Care, Vol. 23, No. 3, June, 1995 98 were dead at time of follow-up. Of the remaining 150 patients, 136 were able to be contacted (90.6070). Incomplete responses were obtained from 14 patients. Information was obtained with the help of the family in the case of language or reading difficulties (23 patients) and with the help of a nurse or doctor in 10 patients.
Health Questionnaire
The answers given to the general questions were classified by one of the authors on the basis of the reported effect of health state on daily life. No health problems were reported by 25070; 47% had minor problems; 15% had major problems; and 13% had severe health problems. Hospital readmission since the initial treatment in the ICV was common (63.4% of patients, average 1.65 admissions); 78.9% of patients were taking medication (average 3.2 types, range 0-18). On the word scale, health was described by the patient as excellent-4%, good-27%, satisfactory-25.4%, fair-28.7%, poor-12.3% and terrible-2.5%. There was good correlation between the word scale description, and the Rosser Index score (Rank correlation coefficient 0.67).
Psychological Sequelae
In response to direct questions, 26% of survivors reported "some" and 6% reported "lots of" worries related to their treatment in the ICV three years previously. These psychological sequelae affected their quality of life adversely. Some patients, however, reported that the episode of treatment in Intensive Care had caused psychological benefit. For these patients, this was a "growth experience", with "positive" psychological sequelae.
Quality of Life Assessment
Of the 136 survivors asked to complete the York/ Rosser Index questionnaire, answers enabled assessment of disability in 132 patients (88.5% of total survivors), and distress assessments in 122 (81.9%): Difficulties with the distress assessment appeared to be due to comprehension problems, emotional objections, or due to acquired neurological deficit (four patients). These patients were assigned the modal distress rating for their diagnostic group. A quality of life (Rosser Index) value was produced for each survivor. The average quality of life values for each diagnostic group and for groups with different severity of illness (APACHE II score) are shown (Tables 3 and 
Outcomes and Costs for Different Patient Groups
The outcome in QALYs, cost of treatment, total and marginal cost-effectiveness of treatment for each patient was calculated as described above. The average daily bed costs for Liverpool Hospital during 1986 was AUD $386. This was somewhat higher than most Australian general hospitals, but less than Australian tertiary referral hospitals 35 • The results shown are based on data collected and analysed using innovative methodology and unrefined techniques. Because of the nature of the data, complex statistical analysis of the results is not justified. Despite these limitations, valid and important conclusions can be made from the results.
The cost of treatment during the initial admission had no correlation with longterm outcome in terms of QALYs. Results varied markedly between diagnostic groups (Table 3) and between groups with different severity of illness (Table 4 ). Trauma patients were the most costly to treat per patient, but were more costeffective than any group, except asthmatics. Patients with cardiogenic pulmonary oedema were less costeffective to treat than others, due to their poor outcome. Table 4 shows that the total cost per admission fell at high severity of illness, since many patients died soon after admission. In patients with high APACHE II scores, the marginal cost-effectiveness of ICU treatment was less than total cost-effectiveness, suggesting that treatment of these patients outside ICU would be economically irrational. The results of estimated cost per discounted QALY for each patient group can be compared with that estimated for other medical interventions in the setting of the Australian health system ( Table 5) 33. Although allowance must be made for the unrefined nature of the data presented in this report, the estimated costeffectiveness of ICU treatment is less than one-tenth of the estimated cost-effectiveness of some commonly accepted medical interventions.
DISCUSSION
This study examines the feasibility of applying the ideas of cost utility theory and quality adjusted life years (QALYs) to patient outcome evaluation in the clinical setting. This paper is presented primarily as a report of methodology for debate and discussion. Most work using QALYs has been based on indirect estimates of costs and patient outcomes, and has not directly evaluated treatment of heterogeneous groups of patients such as ICU patients. These results attempt to quantify outcome in terms of QALYs after Intensive Care. As the methodology becomes more sophisticated, these early results will and should be questioned.
The results from the first part of the questionnaire tend to support those found in other follow-up studies Hospital readmission was common, most patients were taking medication, and general questions suggested one quarter had major health problems. Despite this, most patients described their health as "fair" or better, and prolonged survival with unacceptable quality of life does not appear to be common.
In the second part of the questionnaire, specific enquiry for psychological sequelae following treatment in Intensive Care revealed a high incidence of such problems than had previously been reported. In some cases, this adversely affected the patient's quality of life. Counselling, or other interventions to anticipate and reduce such sequelae, may be appropriate 39 .
The third part of the questionnaire attempted to quantify the quality of life of each patient. The science of evaluation of quality of life must be regarded as being in developmental stages and there are many unresolved issues. Quality of life is, like pain, a subjective experience, and measurement is controversial. For the purposes of outcome assessment using QALYs, a valid measure must be sensitive to all factors affecting quality of life, and must be able to quantify these factors in terms of equivalence to duration of survival lO ,4{). The use of the York Centre for Health Economics Questionnaire to derive a Rosser Index value was among the best available patient-based methods of evaluating quality of life at the time of the investigation lO ,41.
The ability of patients to give appropriate responses is a major requirement of any questionnaire. The York Centre for Health Economics Questionnaire was modified by substitution of a visual integer scale for the visual analog scale. Previous studies comparing visual analog and category rating methods have not shown great differences 42 ,43, so that substitution of the visual analog scale by the visual integer scale should not alter validity. This produced a much higher rate of appropriate responses, and enabled administration or verification of the questionnaire by telephone interview in some cases. The modified York Centre for Health Economics Questionnaire used in this study was able to be completed by most of the patients contacted, although not some with neurological disorders. Analysis of the completed questionnaire took less than ten minutes. The measurement of quality of life using these techniques appears to be feasible for most patients.
In this study patient follow-up was at a single point. It would obviously be better to have multiple episodes of quality of life evaluation (for example at six-monthly intervals). As this was not possible in this study, an estimate was made of the quality of life value for patients who had died in the intervening three years. The quality of life of those who died within three years would normally be expected to be somewhat lower than longterm survivors because these patients were sicker; however it can be equally argued that in the initial period after discharge from Intensive Care, quality of life was higher (even "super normal"), as this time of life was seen as an unexpected extension of life for these patients. The variables involved could suggest the quality of life was higher or lower than "average" patients. Hence we felt that assigning these patients a quality of life value equal to the average was as valid as any other method other than directly assessing these patients.
Quality of life assessment in the presence of a neurological disorder is a particular problem. In this study there were very few patients with significant neurological impairment at the time of outcome assessment, so this factor does not have a significant effect on the results. The assessment of quality of life in the presence of neurological disorder has not been addressed satisfactorily in the quality of life literature. This unresolved issue shall limit the usefulness of quality of life assessment after Intensive Care in cost utility studies.
The accurate measurement of quality of life is relatively unimportant in studies of outcome after ICU, since the main end point is survival rather than change in quality of life. Nevertheless, it is appropriate to attempt to address the issue in any study of patient outcome. The available techniques for quantification of quality of life need further improvement to facilitate such studies [12] [13] [14] [15] 41, 44 . Information gained in patientbased studies using the imperfect techniques currently available will aid such improvement.
Previously published work has suggested that longterm survivors of Intensive Care treatment have an ageadjusted life expectancy approaching that of the general population, and a stable quality of lifeI9. 21-24,28,45. This assumption was used as the basis of survival estimates for the QALY calculation in this study. In the patients studied, three-year survival varied markedly between diagnostic groups. In particular, patients with asthma or pulmonary oedema had a high "late" mortality, compared with age-specific life expectancy. Better knowledge of longterm survival of different patient groups, and the stability of quality of life, will increase the accuracy of the calculation of outcome in QALYs.
One of the criticisms of the use of QALYs as a method of comparing patient outcome is the inherent bias towards young patients with prolonged survival. Discounting of survival over time, as in this study, is an attempt to reduce this bias. Discounting at 5OJo annually is a common method. The rationale and methods for discounting have been discussed in detail elsewhere 40 .
Some patients in this study may have survived with less "aggressive" treatment. Ideally, the marginal effectiveness of ICU treatment would be evaluated using disease-specific relative survival rates derived from randomized clinical trials comparing patient outcome following ICU treatment with that achieved following alternative treatment, such as standard ward care. However, it is ethically and pragmatically difficult to conduct the randomized clinical trial to enable this comparison. We cannot foresee such statistics becoming available. In their absence, the marginal effectiveness of ICU treatment compared with standard ward treatment was calculated using estimates by experienced clinicians of the relative survival of patients with different severity of illness. Experienced intensivists predict patient mortality in ICU as accurately as quantitative models 46 • These estimates may be used as a guide to establishing which patients gain most benefit (QALYs) as a result of ICU compared with standard ward treatment. In our series, the marginal effectiveness of ICU treatment was greatest when the acute illness was moderately severe (APACHE 11 score 20-20) and where a "good" outcome could be expected (asthma, trauma, or general medical patients).
The estimation of costs of treatment used in this study was based on duration of treatment in ICU and in hospital, a "top-down" approach. Similar methods for cost-estimation have been used in previous studies of the economics of treatment in an ICU 2o ,24,3I,J2,J6,47.49. This method of costing is particularly appropriate in hospitals or health systems with centralized (nonpatient centred) budget control. In some public health systems, it is the only feasible technique 24 . The Australian public hospital system has, until recently, been based on centralized budget control. Other methods of costings would be more appropriate in other health systems.
A previous Australian study showed that treatment in a comparable ICU was approximately three times more costly than normal ward treatment, and that individual patient variation had little effect on admission costs, most of which were "fixed" (e.g. salaries, equipment)Jo. Other studies have tended to confirm thisl,24.J2,45. The cost of outpatient treatment during recovery from the initial illness was assumed to be relatively small, and was ignored. Indirect costs such as lost productivity, costs to the family arising from patient survival, and ongoing costs due to chronic illness were not considered. Whether such costs should be included in economic evaluation of health interventions remains controversial 40 .
The high cost of treatment in ICU has been cited as a reason to restrict such treatment 2 ,4. Previous investigations of the cost-effectiveness of ICUs have produced conflicting results. The general perception of ICUs as being wasteful of hospital resources has remained 2 . This study was an attempt to improve upon previous investigations of the cost-effectiveness of treatment in ICU. In this study, the costs of treatment, and patient outcome, were calculated using various assumed and estimated values. More precise values would improve the accuracy of these calculations, but the results enable some general observations to be made.
There was no correlation between cost of treatment and outcome for individual patients or patient groups. Expensive patients may be cost-effective (low cost per QALY), and the high cost of treating a patient is not of itself a reason not to treat that patient. There was a strong correlation between APACHE 11 score and total cost per QALY, suggesting that the sickest patients give "least value for money". Paradoxically, the marginal cost of treatment in ICU compared with standard ward treatment is not strongly correlated with severity of illness. This suggests that if severely ill patients are treated at all, it may be economically justifiable to treat them in ICU. It may even be economically irrational to treat these patients outside an ICU. The ethical dilemmas presented by this conclusion are great.
Because cost-effectiveness can be expressed in terms of cost per QALY, a variety of medical interventions can be compared (Table 5 ). While cost per QALY varies between diagnostic groups and severity of illness, treatment in our ICU appears reasonably cost-effective when compared with other medical interventions. Cost-comparisons based on one unit need to be made with caution, since local characteristics of an ICU will affect the cost-effectiveness of treatment in that unit. These characteristics include admission policy, patient case-mix, and the length of treatment of those without worthwhile outcome. The results obtained in this study are in general agreement with other studies of outcome and costs of ICU treatment that have attempted to estimate cost per life-year "saved' ' 20,24,36,49. Despite the very wide margin for error implicit in the study due to the developmental nature of the methodology used, important conclusions can be made. The apparent cost per QALY of treatment in our Intensive Care Unit was less than one-tenth of what would be regarded as unacceptable in economic terms. The results of this study suggests that treatment in a general hospital ICU is economically justified, assuming appropriate selection criteria are used, and clinically inappropriate treatment is avoided. Reduction of financial support for ICU-related services (e.g. trauma) on the basis the high cost of those services may be illogical while other services, such as mammographic screening, or treatment of hypertension, are continued ( Table 5 ).
In our hospital, this study has altered clinical practice in a number of ways. A High Dependency Unit has been developed as a more cost-effective way to treat some patients, such as those with cardiogenic pulmonary oedema, or following vascular surgery. Patients with acute severe asthma are treated "aggressively", and are actively followed up in an attempt to reduce late mortality. Increased resources have been devoted to the treatment of trauma.
In addition, the clinicians involved in this study have become more aware of the complexities. of estimating cost-effectiveness of clinical practice. Clinicians making resource allocation decisions may mistakenly restrict cost-effective care because they perceive it to be unjustifiably expensive. The reverse also occurs. There is a great need for more sophisticated understanding of health economics by clinicians, and greater comprehension of clinical problems by health economists.
In summary, quantification of patient outcome using QALYs is feasible in a general hospital ICU. This can provide greater understanding of patient outcome which may guide clinical practice. It may also be used to estimate and compare cost-effectiveness of treatment. Methods for evaluating quality of life, particularly for patients with neurological disorders, need to be improved. Larger and more sophisticated studies of patient outcome and costs need to be undertaken to accurately evaluate ICU treatment. In the absence of such studies, this study suggests that for most patients, if a worthwhile clinical outcome is predicted, treatment in ICU is economically justifiable.
APPENDIX 1: Measurement of Quality of Life
Various methods for measuring quality of life have been proposedJ1,50-s,. The majority cannot be used for calculating QALYs, since the quality of life scale is not related to duration of life (i.e. a utility weighting). The Rosser Index, one system for generating utility weightings, measures quality of life based on disability and psychological distress". The University of York Centre for Health Economics has designed a selfcompleted questionnaire to facilitate evaluation of quality of life according to Rosser categories \7 The York Centre for Health Economics Questionnaire categorizes the patient into one of eight different levels of disability, using dimensions of mobility, usual activities, self-care, and social function. Disability is classified by severity from I to VIII, where I is no disability and VIII is unconsciousness. Categorization of distress is performed using the respondents' own Anaesthesia and Intensive Care, Vot. 23, No, 3, June, 1995 evaluation of their distress due to a 13 different "feelings" (e.g. "feeling sad or depressed", "pain", "loneliness"). Based on these evaluations, distress is categorized as A, none; B, mild; C, moderate; and D, severe.
The eight levels of disability and four grades of distress are combined to classify the patient into one of 29 "life-states". The most severe level of disability is unconsciousness, which does not have a distress component. Each different life-state has a value on a scale with two fixed points: complete health = 1, and dead = O. Example values for various life-states are as shown in Table 6 . The York Centre for Health Economics Questionnaire and Rosser Index was modified in two ways for this study. In the original form, a visual analog scale is used for the distress rating, with respondents marking a point between extremes of "no distress" and "extreme distress". In our preliminary work, difficulty was found obtaining meaningful responses from patients using the visual analog scale, even after explanation and examples. Elderly patients, who comprised many of our subjects, were a particular problem. We therefore used a "visual integer scale": the numbers 0-10 printed along a line next to the feeling description. Respondents were asked to circle the number corresponding to the severity of their distress due to the feeling described, where O=no distress; and 10 = severe distress. This modification produced a much higher rate of completion of the questionnaire.
The two worst life-states in the Rosser Index are given negative values, implying that the quality of life is "worse than death". The concept of a negative quality of life is controversial, and in this study these life-states were scored as zero values.
The questionnaire used in this study is available from the authors on request. study was funded by the South Western Sydney Area Health Service.
